logo RIMA
logo UFRRJ

  1. Repositório de Múltiplos Acervos da UFRRJ
  2. Teses e Dissertações
  3. Programa de Pós-Graduação em Medicina Veterinária (Patologia e Ciências Clínicas)
  4. Doutorado em Medicina Veterinária (Patologia e Ciências Clínicas)
Please use this identifier to cite or link to this item: https://rima.ufrrj.br/jspui/handle/20.500.14407/10140
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOliveira, Renato Leão Sá de
dc.date.accessioned2023-12-21T18:57:55Z-
dc.date.available2023-12-21T18:57:55Z-
dc.date.issued2019-07-30
dc.identifier.citationOLIVEIRA, Renato Leão Sá de. Dexmedetomidina associada a nalbufina, butorfanol ou metadona: comparação da sedação, influência sobre a dose de indução anestésica do propofol e na reação a cateterização venosa com ou sem o uso do creme EMLA em gatos. 2019. 48 f. Tese (Doutorado em Medicina Veterinária) - Instituto de Veterinária, Programa de Pós-Graduação em Medicina Veterinária (Patologia e Ciências Clínicas), Universidade Federal Rural do Rio de Janeiro, Seropédica, 2019.por
dc.identifier.urihttps://rima.ufrrj.br/jspui/handle/20.500.14407/10140-
dc.description.abstractO presente trabalho foi desenvolvido no setor de medicina felina do Hospital Veterinário da Universidade Federal Rural do Rio de Janeiro. Foram utilizadas 42 gatas destinadas à castração eletiva e todas foram enquadrados pela classificação de risco da American Society of Anesthesiologists (ASA) como ASA I ou II para serem incluídas no estudo. Os objetivos foram, primariamente, avaliar a sedação e o efeito sobre a dose de indução de propofol de três protocolos de medicação pré-anestésica com dexmedetomidina (0,01 mg.kg-1) associada à nalbufina (DN; 0,3 mg.kg-1), butorfanol (DB; 0,3 mg.kg-1) ou metadona (DM; 0,3 mg.kg-1). Secundariamente, os animais tratados com dexmedetomidina associada à nalbufina ou metadona foram avaliados quanto à eficácia da aplicação do creme de lidocaína-prilocaína (creme EMLA) por 20 minutos a fim de reduzir sua reação à cateterização venosa, sendo metade dos animais de cada grupo tratada com o creme e a outra metade controle negativo. Os animais foram aleatoriamente alocados nos diferentes tratamentos e, após aclimatação, os receberam por aplicação intramuscular na musculatura epaxial lombar. Foi registrado o escore de sedação nos tempos 10, 20 e 30 minutos após a aplicação dos tratamentos. Nos grupos DN e DM os animais receberam a aplicação do creme EMLA 10 minutos após a aplicação da medicação pré-anestésica. Ao fim da avaliação da sedação 30 minutos após a aplicação dos tratamentos, os animais eram submetidos à cateterização venosa na veia cefálica esquerda, com avaliação da reação destes ao procedimento nos grupos DN e DM, realizada a indução anestésica com propofol (5 mg.kg.min-1) e registrada a quantidade necessária para a indução anestésica. Os escores de sedação não foram diferentes entre os grupos, sendo observado um incremento da sedação ao longo do tempo nos três grupos, com sedação intensa em todos os grupos no tempo 30 minutos após a administração dos protocolos. Da mesma maneira, o tempo para os animais virem a decúbito lateral não diferiu entre os grupos. As doses de propofol para indução não diferiram entre os grupos. O principal efeito adverso observado foi êmese, presente em 0/14 gatos em DN, 2/14 em DB e 2/14 em DM. Para a reação à cateterização venosa foi possível observar redução significativa nos grupos tratados com creme EMLA em comparação aos animais controle. A ação sinérgica ou ao menos aditiva entre agonistas α-2 adrenérgicos e opioides deve ser considerada como um dos principais fatores que levaram aos níveis intensos de sedação e curto tempo de latência dos protocolos. Concluímos que a sedação com nalbufina, metadona ou butorfanol, associados à dexmedetomidina, nas presentes doses, produz sedação intensa, com curto tempo de latência, baixa incidência de êmese e pode reduzir o requerimento de propofol para indução anestésica em gatos. Adicionalmente, a combinação de nalbufina ou metadona com dexmedetomidina, nas presentes doses, quando associadas ao creme EMLA, podem abolir as respostas dos animais à cateterização venosa.por
dc.description.sponsorshipCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorpor
dc.formatapplication/pdf*
dc.languageporpor
dc.publisherUniversidade Federal Rural do Rio de Janeiropor
dc.rightsAcesso Abertopor
dc.subjectnalbufinapor
dc.subjectmetadonapor
dc.subjectbutorfanolpor
dc.subjectdexmedetomidinapor
dc.subjectsedaçãopor
dc.subjectgatospor
dc.subjectnalbuphineeng
dc.subjectmethadoneeng
dc.subjectbutorphanoleng
dc.subjectdexmedetomidineeng
dc.subjectsedationeng
dc.subjectcatseng
dc.titleDexmedetomidina associada a nalbufina, butorfanol ou metadona: comparação da sedação, influência sobre a dose de indução anestésica do propofol e na reação a cateterização venosa com ou sem o uso do creme EMLA em gatospor
dc.title.alternativeDexmedetomidine associated to nalbuphine, butorphanol or methadone: comparison of sedation, influence on propofol dose for anesthetic induction and the reaction to venous catheterization with or without EMLA creameng
dc.typeTesepor
dc.description.abstractOtherThe present study was developed at the feline medicine service of the Universidade Federal Rural do Rio de Janeiro Veterinary teaching hospital. Forty-two female cats recruited for spaying were enrolled in the study. All animals were classified by the American Society of Anesthesiologists (ASA) risk classification as ASA I or II to be included in the study. The main goal of the study was to evaluate the sedation and the effects over the propofol dose needed to induce anesthesia in cats premedicated with dexmedetomidine (0,01 mg.kg-1) associated with nalbuphine (DN; 0,3 mg.kg-1), butorphanol (DB; 0,3 mg.kg-1) or methadone (DM; 0,3 mg.kg-1). The secondary goal was to evaluate the efficacy of lidocaine-prilocaine cream (EMLA cream) in reducing the response to venous catheterization in cats of groups DN and DM by applying the cream for 20 minutes in 6 cats in each group and not applying in other 6 cats to create a negative control. Cats were randomly allocated in of the three premedication groups and after acclimation received in the quadriceps muscles one of the protocols. Sedation scores were recorded 10, 20 and 30 minutes after premedication. Six cats in each of DN and DM groups had applied on the antebrachium EMLA cream 10 minutes after premedication. After sedation scores 30 minutes after premedication cats had a catheter placed on the left cephalic vein and the animals enrolled to score reaction to catheter placement had it done. Anesthetic induction with propofol (5 mg.kg.min-1) was then performed and the amount of propofol needed to induce anesthesia recorded. Sedation scores did not differ among groups but an increment in sedation was observed along time in all three groups with intense sedation 30 minutes after premedication. In the same fashion the time for lateral recumbency did not differ among groups. Propofol dose to induce anesthesia also did not differ among premedication groups. The main side effect was emesis, present in 0/14 cats on DN, 2/14 cats in DB and 2/14 cats in DM. The reaction to catheter placement was lower in treated cats when compared to control cats. The synergistic or at least additive action between α-2 adrenoceptor agonists and opioids must be considered as one of the main factors leading to the high levels of sedation with short onset. We conclude that sedation with nalbuphine, butorphanol or methadone, associated with dexmedetomidine, at the present doses, produce intense sedation with shot onset, low incidence of emesis and may reduce the amount of propofol needed to induce anesthesia. Additionally, the combination of nalbuphine or methadone with dexmedetomidine, at the present doses, when associated with EMLA cream may abolish the reaction to intravenous catheter placement in cats.eng
dc.contributor.advisor1Souza, Heloisa Justen Moreira de
dc.contributor.advisor1IDCPF: 946.916.307-91por
dc.contributor.advisor-co1Soares, João Henrique Neves
dc.contributor.advisor-co1IDCPF: 037.638.297-09por
dc.contributor.referee1Marinho, Bruno Guimarães
dc.contributor.referee2Fernandes, Julio Israel
dc.contributor.referee3Santos, Paulo Sérgio Patto dos
dc.contributor.referee4Ascoli, Fábio Otero
dc.creator.IDCPF: 102.807.547-29por
dc.creator.Latteshttp://lattes.cnpq.br/2919290516434120por
dc.publisher.countryBrasilpor
dc.publisher.departmentInstituto de Veterináriapor
dc.publisher.initialsUFRRJpor
dc.publisher.programPrograma de Pós-Graduação em Medicina Veterinária (Patologia e Ciências Clínicas)por
dc.relation.referencesCAPÍTULO I: ANSAH; RAEKALLIO; VAINIO. Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, v. 21, n. 5, p. 380–387, 1998. BHALLA, R. J. et al. Comparison of intramuscular butorphanol and buprenorphine combined with dexmedetomidine for sedation in cats. Journal of Feline Medicine and Surgery, v. 20, n. 4, p. 325–331, 2018. BHANA, N.; GOA, K. L.; MCCLELLAN, K. J. Dexmedetomidine. Drugs, v. 59, n. 2, p. 263– 268, 2000. BIGBY, S. E. et al. Effect of rate of administration of propofol or alfaxalone on induction dose requirements and occurrence of apnea in dogs. Veterinary Anaesthesia and Analgesia, v. 44, n. 6, p. 1267–1275, 2017. BORTOLAMI, E.; MURRELL, J. C.; SLINGSBY, L. S. Methadone in combination with acepromazine as premedication prior to neutering in the cat. Veterinary Anaesthesia and Analgesia, v. 40, n. 2, p. 181–193, 2013. CHABOT-DORÉ, A.-J. et al. Analgesic synergy between opioid and α 2 -adrenoceptors. British Journal of Pharmacology, v. 172, n. 2, p. 388–402, 2015. CHEN, J.-C. et al. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sciences, v. 52, n. 4, p. 389–396, 1993. CODD, E. E. et al. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. The Journal of Pharmacology and Experimental Therapeutics, v. 274, n. 3, p. 1263–1270, 1995. COHEN, S. E. et al. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesthesia & Analgesia, v. 75, n. 5, p. 747–52, 1992. DE SOUZA, E. B.; SCHMIDT, W. K.; KUHAR, M. J. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. The Journal of Pharmacology and Experimental Therapeutics, v. 244, n. 1, p. 391–402, 1988. DOBROMYLSKYJ, P. Assessment of methadone as an anaesthetic premedicant in cats. Journal of Small Animal Practice, v. 34, n. 12, p. 604–608, 1993. FERRARI, A. et al. Methadone - metabolism, pharmacokinetics and interactions. Pharmacological Research, v. 50, n. 6, p. 551–9, 2004. FERREIRA, T. H. et al. Plasma concentrations and behavioral antinociceptive, and physiologic effects of methadone after intravenous and oral transmucosal administration in cats. American Journal of Veterinary Research, v. 72, n. 6, p. 764–771, 2011a. FERREIRA, T. H. et al. Determination of the sevoflurane sparing effect of methadone in cats. Veterinary Anaesthesia and Analgesia, v. 38, n. 4, p. 310–9, 2011b. FRAZILIO, F. de O. et al. Effects of epidural nalbuphine on intraoperative isoflurane and postoperative analgesic requirements in dogs. Acta Cirurgica Brasileira, v. 29, n. 1, p. 38–46, 2014. GAL, T. J.; DIFAZIO, C. A.; MOSCICKI, J. Analgesic and respiratory depressant activity of nalbuphine: a comparison with morphine. Anesthesiology, v. 57, n. 5, p. 367–74, 1982. GOMES, V. H. et al. Comparison of the sedative effects of nalbuphine and butorphanol, alone or in combination with acepromazine in dogs. Veterinary Anaesthesia and Analgesia, v. 45, n. 1, p. 68–72, 2018. GRANHOLM, M. et al. Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole. Veterinary Anaesthesia and Analgesia, v. 33, n. 4, p. 214–223, 2006. GUNION, M. W.; MARCHIONNE, A. M.; ANDERSON, C. T. . Use of the mixed agonist– antagonist nalbuphine in opioid based analgesia. Acute Pain, v. 6, n. 1, p. 29–39, 2004. INTURRISI, C. E. Clinical Pharmacology of Opioids for Pain. The Clinical Journal of Pain, v. 18, n. Supplement, p. S3–S13, 2002. KRISTENSEN, K.; CHRISTENSEN, C. B.; CHRISTRUP, L. L. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sciences, v. 56, n. 2, p. 45–50, 1994. LUDBROOK, G. L. et al. The Effect of Rate of Administration on Brain Concentrations of Propofol in Sheep. Anesthesia & Analgesia, v. 86, n. 6, p. 1301–1306, 1998. MAIR, A.; KLOEPPEL, H.; TICEHURST, K. A comparison of low dose tiletamine-zolazepam or acepromazine combined with methadone for pre-anaesthetic medication in cats. Veterinary Anaesthesia and Analgesia, v. 41, n. 6, p. 630–635, 2014. MANTZ, J.; JOSSERAND, J.; HAMADA, S. Dexmedetomidine: new insights. European Journal of Anaesthesiology, v. 28, n. 1, p. 3–6, 2011. MARTIN, W. R. Pharmacology of opioids. Pharmacological Reviews, v. 35, n. 4, p. 283– 323, 1983. MCSWEENEY, P. M. et al. Clinical efficacy and safety of dexmedetomidine used as a preanesthetic prior to general anesthesia in cats. Journal of the American Veterinary Medical Association, v. 240, n. 4, p. 404–12, 2012. MENDES, G. M. et al. Clinical use of dexmedetomidine as premedicant in cats undergoing propofol-sevoflurane anaesthesia. Journal of Feline Medicine and Surgery, v. 5, n. 5, p. 265– 70, 2003. MONTEIRO, E. R. et al. Efeitos sedativo e cardiorrespiratório da administração da metadona, isoladamente ou em associação à acepromazina ou xilazina, em gatos. Brazilian Journal of Veterinary Research and Animal Science, v. 45, n. 4, p. 289–297, 2008. MURPHY, M. R.; HUG, C. C. The enflurane sparing effect of morphine, butorphanol, and nalbuphine. Anesthesiology, v. 57, n. 6, p. 489–92, 1982. MURRELL, J. C. Clinical use of methadone in cats and dogs. Companion Animal, v. 16, n. 5, p. 56–61, 2011. NAGORE, L. et al. Sedative effects of dexmedetomidine, dexmedetomidine-pethidine and dexmedetomidine-butorphanol in cats. Journal of veterinary pharmacology and therapeutics, v. 36, n. 3, p. 222–8, 2013. NARVER, H. L. Nalbuphine, a non-controlled opioid analgesic, and its potential use in research mice. Lab Animal, v. 44, n. 3, p. 106–110, 2015. OLIVEIRA, R. L. et al. Effect of administration rate on propofol requirement in cats. Journal of Feline Medicine and Surgery, v. 20, n. 2, p. 91–94, 2018. OSSIPOV, M. H. et al. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology, v. 73, n. 6, p. 1227–35, 1990. PAPASTEFANOU, A. K. et al. The effect of butorphanol on the incidence of dexmedetomidine-induced emesis in cats. Veterinary Anaesthesia and Analgesia, v. 42, n. 6, p. 608–613, 2015. PYPENDOP, B. H.; HONKAVAARA, J.; ILKIW, J. E. Cardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats. Veterinary Anaesthesia and Analgesia, v. 44, n. 1, p. 52–62, 2017. PYPENDOP, B. H.; ILKIW, J. E. Pharmacokinetics of dexmedetomidine after intravenous administration of a bolus to cats. American Journal of Veterinary Research, v. 75, n. 5, p. 441–5, 2014. PYPENDOP, B. H.; ILKIW, J. E.; SHILO-BENJAMINI, Y. Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats. Journal of Veterinary Pharmacology and Therapeutics, v. 37, n. 3, p. 295–300, 2014. RANKIN, D. C. Sedatives and Tranquilizers. In: GRIMM, K. A. et al. (Ed.). Veterinary Anesthesia and Analgesia The Fifth Edition of Lumb and Jones. 5th. ed. Oxford: Wiley- Blackwell, 2015. p. 196–206. ROBERTSON, S. A. et al. AAFP Feline Anesthesia Guidelines. Journal of Feline Medicine and Surgery, v. 20, n. 7, p. 602–634, 2018. ROBERTSON, S. A.; TAYLOR, P. M. Pain management in cats: past, present and future. Part 2. Treatment of pain: clinical pharmacology. Journal of Feline Medicine and Surgery, v. 6, n. 5, p. 321–33, 2004. SAWYER, D. C.; RECH, R. H. Analgesia and behavioral effects of butorphanol, nalbuphine, and pentazocine in the cat. Journal of the American Animal Hospital Association, v. 23, p. 438–446, 1987. SCHMIDT, W. K. et al. Nalbuphine. Drug and Alcohol Dependence, v. 14, n. 3–4, p. 339– 362, 1985. SELF, I. A. et al. Effect of muscle injection site on preanaesthetic sedation in dogs. Veterinary Record, v. 164, n. 11, p. 323–323, 2009. SELMI, A. L. et al. Evaluation of the sedative and cardiorespiratory effects of dexmedetomidine, dexmedetomidine-butorphanol, and dexmedetomidine-ketamine in cats. Journal of the American Veterinary Medical Association, v. 222, n. 1, p. 37–41, 2003. SIAO, K. T. et al. Hemodynamic effects of dexmedetomidine, with and without MK-467, following intramuscular administration in cats anesthetized with isoflurane. Veterinary Anaesthesia and Analgesia, v. 44, n. 5, p. 1101–1115, 2017. SIMON, B. T.; STEAGALL, P. V. The present and future of opioid analgesics in small animal practice. Journal of Veterinary Pharmacology and Therapeutics, v. 40, n. 4, p. 315–326, 2017. SINCLAIR, M. D. A Review of the Physiological Effects of Alpha2-Agonists Related to the Clinical Use of Medetomidine in Small Animal Practice. The Canadian Veterinary Journal - La Revue Vétérinaire Canadienne, v. 44, n. 11, p. 885–897, 2003. SLINGSBY, L. S.; TAYLOR, P. M. Thermal antinociception after dexmedetomidine administration in cats: a dose-finding study. Journal of Veterinary Pharmacology and Therapeutics, v. 31, n. 2, p. 135–42, 2008. SMITH, C. K. et al. Effect of dexmedetomidine on the minimum infusion rate of propofol preventing movement in dogs. Veterinary Anaesthesia and Analgesia, v. 44, n. 6, p. 1287– 1295, 2017. STEIN, C. Opioid Receptors. Annual Review of Medicine, v. 67, n. 1, p. 433–451, 2016. STOKES, D. N.; HUTTON, P. Rate-dependent induction phenomena with propofol: implications for the relative potency of intravenous anesthetics. Anesthesia & Analgesia, v. 72, n. 5, p. 578–83, 1991. TORAD, F. A.; HASSAN, E. A. Sedative, analgesic, and behavioral effects of nalbuphinexylazine and nalbuphine-midazolam combinations in dogs. Journal of Veterinary Behavior, v. 28, p. 40–45, 2018. TRESCOT, A. M. et al. Opioid pharmacology. Pain Physician, v. 11, n. 2 Suppl, p. S133-53, 2008. WANG, J. Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects. Regional Anesthesia and Pain Medicine, v. 23, n. 5, p. 479–484, 1998. WARNE, L. N. et al. Comparison of perioperative analgesic efficacy between methadone and butorphanol in cats. Journal of the American Veterinary Medical Association, v. 243, n. 6, p. 844–850, 2013. WILLEY, J. L. et al. Evaluation and comparison of xylazine hydrochloride and dexmedetomidine hydrochloride for the induction of emesis in cats: 47 cases (2007–2013). Journal of the American Veterinary Medical Association, v. 248, n. 8, p. 923–928, 2016. ZENG, Z. et al. A Comparision of Nalbuphine with Morphine for Analgesic Effects and Safety : Meta-Analysis of Randomized Controlled Trials. Scientific Reports, v. 5, n. 1, p. 10927, 2015. ========================== CAPÍTULO II: ARAUJO, D. R. de; PAULA, E. de; FRACETO, L. F. Anestésicos locais: interação com membranas biológicas e com o canal de sódio voltagem-dependente. Química Nova, v. 31, n. 7, p. 1775–1783, 2008. BORTOLAMI, E.; MURRELL, J. C.; SLINGSBY, L. S. Methadone in combination with acepromazine as premedication prior to neutering in the cat. Veterinary Anaesthesia and Analgesia, v. 40, n. 2, p. 181–193, 2013. CARNEY, H. C. et al. AAFP and ISFM Feline-Friendly Nursing Care Guidelines. Journal of Feline Medicine and Surgery, v. 14, n. 5, p. 337–349, 2012. DE WAARD-VAN DER SPEK, F. B.; VAN DEN BERG, G. M.; ORANJE, A. P. EMLA Cream: An Improved Local Anesthetic. Review of Current Literature. Pediatric Dermatology, v. 9, n. 2, p. 126–131, 1992. EPSTEIN, M. E. et al. 2015 AAHA/AAFP Pain Management Guidelines for Dogs and Cats. Journal of Feline Medicine and Surgery, v. 17, p. 251–272, 2015. FLECKNELL, P. A. Injectable Anaesthetics. In: HALL, L. W.; TAYLOR, P. M. (Ed.). Anaesthesia of the Cat. 1st. ed. London: Baillière Tindall, 1994. p. 129–156. FLECKNELL, P. A.; LILES, J. H.; WILLIAMSON, H. A. The use of lignocaine-prilocaine local anaesthetic cream for pain-free venepuncture in laboratory animals. Laboratory Animals, v. 24, n. 2, p. 142–146, 1990. GAJRAJ, N. M.; PENNANT, J. H.; WATCHA, M. F. Eutectic mixture of local anesthetics (EMLA) cream. Anesthesia & Analgesia, v. 78, n. 3, p. 574–83, 1994. GARCIA, E. R. Local Anesthetics. In: GRIMM, K. A. et al. (Ed.). Lumb and Jones’ Veterinary Anesthesia and Analgesia. 5th. ed. Ames: Wiley-Blackwell, 2015. p. 332–356. GIBBON, K. J. et al. Evaluation of adverse effects of EMLA (lidocaine/prilocaine) cream for the placement of jugular catheters in healthy cats. Journal of Veterinary Pharmacology and Therapeutics, v. 26, n. 6, p. 439–441, 2003. HALLEN, B.; CARLSSON, P.; UPPFELDT, A. Clinical study of a lignocaine-prilocaine cream to relieve the pain of venepuncture. British Journal of Anaesthesia, v. 57, n. 3, p. 326– 328, 1985. HOPKINS, C. S.; BUCKLEY, C. J.; BUSH, G. H. Pain-free injection in infants. Use of a lignocaine-prilocaine cream to prevent pain at intravenous induction of general anaesthesia in 1-5-year-old children. Anaesthesia, v. 43, n. 3, p. 198–201, 1988. JUHLIN, L.; EVERS, H.; BROBERG, F. A lidocaine-prilocaine cream for superficial skin surgery and painful lesions. Acta Dermato-Venereologica, v. 60, n. 6, p. 544–6, 1980. NAGORE, L. et al. Sedative effects of dexmedetomidine, dexmedetomidine-pethidine and dexmedetomidine-butorphanol in cats. Journal of veterinary pharmacology and therapeutics, v. 36, n. 3, p. 222–8, 2013. PYPENDOP, B. H. et al. Hemodynamic effects of dexmedetomidine in isoflurane-anesthetized cats. Veterinary Anaesthesia and Analgesia, v. 38, n. 6, p. 555–567, 2011. STAFFIERI, F.; STEAGALL, P. V. Local Anesthetics and Loco-regional Techniques. In: STEAGALL, P. V.; ROBERTSON, S. A.; TAYLOR, P. M. (Ed.). Feline Anesthesia and Pain Management. 1st. ed. Hoboken: Wiley-Blackwell, 2018. p. 67–88. VAN LOON, F. H. et al. Pain upon inserting a peripheral intravenous catheter: Size does not matter. The Journal of Vascular Access, v. 19, n. 3, p. 258–265, 2018. VAN OOSTROM, H.; KNOWLES, T. G. The clinical efficacy of EMLA cream for intravenous catheter placement in client-owned dogs. Veterinary Anaesthesia and Analgesia, v. 45, n. 5, p. 604–608, 2018.por
dc.subject.cnpqMedicina Veterináriapor
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/67438/2019%20-%20Renato%20Le%c3%a3o%20S%c3%a1%20de%20Oliveira.pdf.jpg*
dc.originais.urihttps://tede.ufrrj.br/jspui/handle/jspui/5214
dc.originais.provenanceSubmitted by Jorge Silva (jorgelmsilva@ufrrj.br) on 2021-11-01T19:19:27Z No. of bitstreams: 1 2019 - Renato Leão Sá de Oliveira.pdf: 3354845 bytes, checksum: 8624905daa82d26832827e977e509e3d (MD5)eng
dc.originais.provenanceMade available in DSpace on 2021-11-01T19:19:27Z (GMT). No. of bitstreams: 1 2019 - Renato Leão Sá de Oliveira.pdf: 3354845 bytes, checksum: 8624905daa82d26832827e977e509e3d (MD5) Previous issue date: 2019-07-30eng
Appears in Collections:Doutorado em Medicina Veterinária (Patologia e Ciências Clínicas)

Se for cadastrado no RIMA, poderá receber informações por email.
Se ainda não tem uma conta, cadastre-se aqui!

Files in This Item:
File Description SizeFormat 
2019 - Renato Leão Sá de Oliveira.pdf3.28 MBAdobe PDFThumbnail
View/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.